Synthetic Biology: Invizyne Technologies (IZTC)

Invizyne Technologies, Inc. (NASDAQ: IZTC) was founded in 2019, headquartered in Monrovia, California, USA, with 29 full-time employees. Invizyne is redefining biological manufacturing, using cell-free multi-step enzyme system to effectively transform natural or renewable resources into highly sought after chemicals.

The article originates from the home of American stocks | encyclopedia of American stocks | account opening and investment of American and Hong Kong stocks- https://www.mg21.com/iztc.html

Invizyne Technologies (IZTC) US Equities Encyclopedia

Invizyne Technologies' biological manufacturing platform (called SimplePath ™） It will become an important alternative to current compound production methods (usually chemical synthesis, natural extraction and synthetic biology). Company uses SimplePath ™ The goal is to achieve efficient production of various chemicals, including drugs, fuels, materials food Additives and new compounds. The article originates from the home of American stocks | encyclopedia of American stocks | account opening and investment of American and Hong Kong stocks- https://www.mg21.com/iztc.html

SimplePath ™ can not only maximize the value of these resources, but also help the development of new compounds, thus opening up new markets and business opportunities. SimplePath of Invizyne Technologies ™ The platform consists of a series of enzyme based modular cascade biological manufacturing systems, which use natural processes to perform complex chemical transformations. These systems can be coupled together or run independently. Each system consists of several key parts (i.e. substrate, enzyme, cofactor, defined operating conditions, selected purification process and other system specific elements), which work together to produce one or more expected products. The article originates from the home of American stocks | encyclopedia of American stocks | account opening and investment of American and Hong Kong stocks- https://www.mg21.com/iztc.html

Invizyne Technologies

Invizyne Technologies' new approach simplifies synthetic biology by completely removing cells and their complexity. Using the company's proprietary and sustainable enzyme system, Invizyne can build simple and efficient chemical production reactors. The production of extracellular release enzymes enables the company to achieve safety, sustainability and diversity in nature, as well as scale in traditional chemical manufacturing. The article originates from the home of American stocks | encyclopedia of American stocks | account opening and investment of American and Hong Kong stocks- https://www.mg21.com/iztc.html

The Invizyne method allows: The article originates from the home of American stocks | encyclopedia of American stocks | account opening and investment of American and Hong Kong stocks- https://www.mg21.com/iztc.html

• Rapid design build test learning cycle can realize rapid optimization
• Higher output due to lack of competition
• Higher titer, non-toxic limit
• Reliable production scale
• Simplify product purification
• CGMP level production

Facts have proved that the company's cell-free platform can effectively produce a variety of compounds: The article originates from the home of American stocks | encyclopedia of American stocks | account opening and investment of American and Hong Kong stocks- https://www.mg21.com/iztc.html

• Natural ingredients: hemp Vegetables, spices, nutrition health products
• Drugs: natural products with therapeutic properties
• Chemicals: daily chemicals, special chemicals

Invizyne Technologies Market and Products

Invizyne's groundbreaking platform has been applied to the production of various target molecules with high value and difficult to manufacture, and has achieved great success in cannabinoids, biofuels and terpenes. The concentrations obtained by the company in these fields are several orders of magnitude higher than those that may be achieved using yeast based methods. The article originates from the home of American stocks | encyclopedia of American stocks | account opening and investment of American and Hong Kong stocks- https://www.mg21.com/iztc.html

Invizyne provides solutions for: The article originates from the home of American stocks | encyclopedia of American stocks | account opening and investment of American and Hong Kong stocks- https://www.mg21.com/iztc.html

• Natural ingredients: cannabinoids, food and Drinks Flavor enhancers, spices, nutritional health products, organic compounds
• Drugs: natural products with therapeutic properties
• Chemicals: daily chemicals, special chemicals, biofuels

Invizyne Technologies (IZTC) US equity investment

On February 9, 2024, Invizyne Technologies submitted to the SEC on Friday IPO It is proposed to raise up to US $17 million through IPO. Invizyne plans to issue 4.3 million shares at $4 to raise $17 million. At the proposed price, the fully diluted market value of Invizyne Technologies will reach $71 million. Invizyne Technologies plans to be listed on NASDAQ with the stock code of IZTC. Public Ventures is the sole bookrunner of this transaction. The article originates from the home of American stocks | encyclopedia of American stocks | account opening and investment of American and Hong Kong stocks- https://www.mg21.com/iztc.html